Lead Sponsor

Novo Nordisk A/S

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•Type 1 diabetes for more than 12 months
•Current treatment: Basal-bolus insulin regimen for more than three months (i.e. at least one daily injection of long-acting insulin (including insulin glargine) and fast-acting insulin with each main meal)
•HbA1c (glycosylated haemoglobin A1c) between 7.0 and 11.0%
•Able and willing to maintain consistent physical activity level throughout the entire study period
•Able and willing to maintain consistent eating habits throughout the entire study period

•Proliferative retinopathy that has required acute treatment within the last six months
•Recurrent major hypoglycaemia or hypoglycaemic unawareness as judged by the Investigator
•Liver, kidney or heart problems as judged by the Investigator
•Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures
•Known or suspected allergy to trial products or related products
•Receipt of any investigational drug within one month prior to this trial